Suppr超能文献

“智能”药物递送系统:双靶向pH响应型药物纳米载体

"SMART" drug delivery systems: double-targeted pH-responsive pharmaceutical nanocarriers.

作者信息

Sawant R M, Hurley J P, Salmaso S, Kale A, Tolcheva E, Levchenko T S, Torchilin V P

机构信息

Department of Pharmaceutical Sciences, Northeastern University, Boston, Massachusetts 02115, USA.

出版信息

Bioconjug Chem. 2006 Jul-Aug;17(4):943-9. doi: 10.1021/bc060080h.

Abstract

To develop targeted pharmaceutical carriers additionally capable of responding to certain local stimuli, such as decreased pH values in tumors or infarcts, targeted long-circulating PEGylated liposomes and PEG-phosphatidylethanolamine (PEG-PE)-based micelles have been prepared with several functions. First, they are capable of targeting a specific cell or organ by attaching the monoclonal antimyosin antibody 2G4 to their surface via pNP-PEG-PE moieties. Second, these liposomes and micelles were additionally modified with biotin or TAT peptide (TATp) moieties attached to the surface of the nanocarrier by using biotin-PE or TATp-PE or TATp-short PEG-PE derivatives. PEG-PE used for liposome surface modification or for micelle preparation was made degradable by inserting the pH-sensitive hydrazone bond between PEG and PE (PEG-Hz-PE). Under normal pH values, biotin and TATp functions on the surface of nanocarriers were "shielded" by long protecting PEG chains (pH-degradable PEG(2000)-PE or PEG(5000)-PE) or by even longer pNP-PEG-PE moieties used to attach antibodies to the nanocarrier (non-pH-degradable PEG(3400)-PE or PEG(5000)-PE). At pH 7.4-8.0, both liposomes and micelles demonstrated high specific binding with 2G4 antibody substrate, myosin, but very limited binding on an avidin column (biotin-containing nanocarriers) or internalization by NIH/3T3 or U-87 cells (TATp-containing nanocarriers). However, upon brief incubation (15-30 min) at lower pH values (pH 5.0-6.0), nanocarriers lost their protective PEG shell because of acidic hydrolysis of PEG-Hz-PE and acquired the ability to become strongly retained on an avidin column (biotin-containing nanocarriers) or effectively internalized by cells via TATp moieties (TATp-containing nanocarriers). We consider this result as the first step in the development of multifunctional stimuli-sensitive pharmaceutical nanocarriers.

摘要

为了开发能够额外响应某些局部刺激(如肿瘤或梗死区域pH值降低)的靶向药物载体,已经制备了具有多种功能的靶向长循环聚乙二醇化脂质体和基于聚乙二醇 - 磷脂酰乙醇胺(PEG - PE)的胶束。首先,它们能够通过对硝基苯 - 聚乙二醇 - 磷脂酰乙醇胺(pNP - PEG - PE)部分将单克隆抗肌球蛋白抗体2G4连接到其表面,从而靶向特定的细胞或器官。其次,通过使用生物素 - 磷脂酰乙醇胺(biotin - PE)、穿膜肽(TAT)肽(TATp)或TATp - 短聚乙二醇 - 磷脂酰乙醇胺衍生物,将生物素或TAT肽(TATp)部分连接到纳米载体表面,对这些脂质体和胶束进行额外修饰。用于脂质体表面修饰或胶束制备的PEG - PE通过在PEG和PE之间插入pH敏感的腙键(PEG - Hz - PE)而变得可降解。在正常pH值下,纳米载体表面的生物素和TATp功能被长的保护性聚乙二醇链(pH可降解的PEG(2000) - PE或PEG(5000) - PE)或用于将抗体连接到纳米载体的更长的pNP - PEG - PE部分(非pH可降解的PEG(3400) - PE或PEG(5000) - PE)“屏蔽”。在pH 7.4 - 8.0时,脂质体和胶束与2G4抗体底物肌球蛋白均表现出高特异性结合,但在抗生物素蛋白柱上(含生物素的纳米载体)的结合非常有限,或在NIH/3T3或U - 87细胞中的内化作用(含TATp的纳米载体)非常有限。然而,在较低pH值(pH 5.0 - 6.0)下短暂孵育(15 - 30分钟)后,由于PEG - Hz - PE的酸水解,纳米载体失去了其保护性聚乙二醇外壳,并获得了在抗生物素蛋白柱上强烈保留的能力(含生物素的纳米载体)或通过TATp部分被细胞有效内化的能力(含TATp的纳米载体)。我们认为这一结果是多功能刺激敏感药物纳米载体开发的第一步。

相似文献

1
"SMART" drug delivery systems: double-targeted pH-responsive pharmaceutical nanocarriers.
Bioconjug Chem. 2006 Jul-Aug;17(4):943-9. doi: 10.1021/bc060080h.
2
3
Environment-responsive multifunctional liposomes.
Methods Mol Biol. 2010;605:213-42. doi: 10.1007/978-1-60327-360-2_15.
4
"Smart" drug carriers: PEGylated TATp-modified pH-sensitive liposomes.
J Liposome Res. 2007;17(3-4):197-203. doi: 10.1080/08982100701525035.
9
Cell-penetrating TAT peptide in drug delivery systems: proteolytic stability requirements.
Drug Deliv. 2011 Jul;18(5):377-84. doi: 10.3109/10717544.2011.567310. Epub 2011 Mar 26.
10
Enhanced transfection of tumor cells in vivo using "Smart" pH-sensitive TAT-modified pegylated liposomes.
J Drug Target. 2007 Aug-Sep;15(7-8):538-45. doi: 10.1080/10611860701498203.

引用本文的文献

2
Lipid-Polymer Hybrid Nanoparticles as a Smart Drug Delivery System for Peptide/Protein Delivery.
Pharmaceutics. 2025 Jun 19;17(6):797. doi: 10.3390/pharmaceutics17060797.
3
Effect of Peptides on the Synthesis, Properties and Wound Healing Capacity of Silver Nanoparticles.
Pharmaceutics. 2023 Oct 16;15(10):2471. doi: 10.3390/pharmaceutics15102471.
4
Effect of the Lipid Landscape on the Efficacy of Cell-Penetrating Peptides.
Cells. 2023 Jun 23;12(13):1700. doi: 10.3390/cells12131700.
5
Pt(II)-PLGA Hybrid in a pH-Responsive Nanoparticle System Targeting Ovarian Cancer.
Pharmaceutics. 2023 Feb 10;15(2):607. doi: 10.3390/pharmaceutics15020607.
6
Modeling of the In Vitro Release Kinetics of Sonosensitive Targeted Liposomes.
Biomedicines. 2022 Dec 5;10(12):3139. doi: 10.3390/biomedicines10123139.
7
Fast Responsive, Reversible Colorimetric Nanoparticle-Hydrogel Complexes for pH Monitoring.
Nanomaterials (Basel). 2022 Nov 20;12(22):4081. doi: 10.3390/nano12224081.
8
Melanin-like nanoparticles: advances in surface modification and tumour photothermal therapy.
J Nanobiotechnology. 2022 Nov 19;20(1):485. doi: 10.1186/s12951-022-01698-x.
9
Peptide therapeutics in the management of metastatic cancers.
RSC Adv. 2022 Aug 2;12(33):21353-21373. doi: 10.1039/d2ra02062a. eCollection 2022 Jul 21.

本文引用的文献

1
Lipid-core micelles for targeted drug delivery.
Curr Drug Deliv. 2005 Oct;2(4):319-27. doi: 10.2174/156720105774370221.
2
ATP-containing immunoliposomes specific for cardiac myosin.
Curr Drug Deliv. 2004 Jan;1(1):1-7. doi: 10.2174/1567201043480063.
3
Recent advances in tumor-targeting anticancer drug conjugates.
Bioorg Med Chem. 2005 Sep 1;13(17):5043-54. doi: 10.1016/j.bmc.2005.04.084.
4
Intracellular delivery of large molecules and small particles by cell-penetrating proteins and peptides.
Adv Drug Deliv Rev. 2005 Feb 28;57(4):637-51. doi: 10.1016/j.addr.2004.10.007. Epub 2004 Dec 22.
6
Recent advances with liposomes as pharmaceutical carriers.
Nat Rev Drug Discov. 2005 Feb;4(2):145-60. doi: 10.1038/nrd1632.
7
Targeted polymeric micelles for delivery of poorly soluble drugs.
Cell Mol Life Sci. 2004 Oct;61(19-20):2549-59. doi: 10.1007/s00018-004-4153-5.
8
Tumor-targeted liposomes: doxorubicin-loaded long-circulating liposomes modified with anti-cancer antibody.
J Control Release. 2004 Nov 5;100(1):135-44. doi: 10.1016/j.jconrel.2004.08.007.
9
Drug delivery of oligonucleotides by peptides.
Eur J Pharm Biopharm. 2004 Sep;58(2):237-51. doi: 10.1016/j.ejpb.2004.03.031.
10
Tumor cell targeting of liposome-entrapped drugs with phospholipid-anchored folic acid-PEG conjugates.
Adv Drug Deliv Rev. 2004 Apr 29;56(8):1177-92. doi: 10.1016/j.addr.2004.01.011.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验